One surprising aspect of the RBPs discussed in this paper is that some proteins are found in the serum of patients and thus are putative non-invasive biomarkers of neuroblastoma (e.g., MKRN3, DHX9) and, possibly, differentially secreted into serum. The gene discussed is MKRN3; the disease is neuroblastoma.